Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, Skoog T, Jules-Clement G, Feld M, Barrientos-Somarribas M, Sinkko H, van den Bogaard EH, Zeeuwen PLJM, Rikken G, Schalkwijk J, Niehues H, Däubener W, Eller SK, Alexander H, Pennino D, Suamela S, Tessas I, Lybeck E, Baran AM, Darban H, Gangwar RS, Gerstel U, Jahn K, Karisola P, Yan L, Hansmann B, Katayama S, Meller S, Bylesjö M, Hupé P, Levi-Schaffer F, Greco D, Ranki A, Schröder JM, Barker J, Kere J, Tsoka S, Lauerma A, Soumelis V, Nestle FO, Homey B, Andersson B, and Alenius H. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019 Oct;10(1):4703. doi: 10.1038/s41467-019-12253-y.

Spekker-Bosker K, Ufermann CM, Oldenburg M, Däubener W, Eller SK. Interplay between IDO1 and iNOS in human retinal pigment epithelial cells. Med Microbiol Immunol. 2019 Jul; doi: 10.1007/s00430-019-00627-4.

Ufermann CM, Domröse A, Babel T, Tersteegen A, Cengiz SC, Eller SK, Spekker-Bosker K, Sorg UR, Förster I, Däubener. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Profileration in Mice. Front. Cell. Infect. Microbiol., 2019 June; doi: 10.3389/fcimb.2019.00184

Spekker-Bosker K, Ufermann CM, Maywald M, Zimmermann A, Domröse A, Woite C, Däubener W, Eller SK. hCMV-Mediated Immune Escape Mechanisms Favor Pathogen Growth and Disturb the Immune Privilege of the Eye. Int J Mol Sci. 2019 Feb;20(4) pii:E858. doi: 10.3390/ijms20040858

Leineweber M, Spekker-Bosker K, Ince V, Schares G, Hemphill A, Eller SK, Däubener W. First Characterization of the Neospora caninum Dense Granule Protein GRA9. Biomed Res Int. 2017 Nov;2017:6746437. doi: 10.1155/2017/6746437.

Nau J, Eller SK, Wenning J, Spekker-Bosker KH, Schroten H, Schwerk C, Hotop A, Groß U, Däubener WExperimental Porcine Toxoplasma Infection as a Representative Model for Human ToxoplasmosisMediators Inflamm. 2017 Aug;2017:3260289. doi: 10.1155/2017/3260289.

Elbers F, Woite C, Antoni V, Stein S, Funakoshi H, Nakamura T, Schares G, Däubener W, Eller SK. Negative Impact of Hypoxia on Tryptophan 2,3-Dioxygenase Function. Mediators Inflamm. 2016;2016:1638916. doi: 10.1155/2016/1638916

Vogel S, Börger V, Peters C, Förster M, Liebfried P, Metzger K, Meisel R, Däubener W, Trapp T, Fischer JC, Gawaz M, Sorg RV. Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ. 2015 Jul;22(7):1219-30. doi: 10.1038/cdd.2014.225

Schlüter D, Däubener W, Schares G, Groß U, Pleyer U, Lüder C. Animals are key to human toxoplasmosis. Int J Med Microbiol. 2014 Oct;304(7):917-29. doi: 10.1016/j.ijmm.2014.09.002

Herrmann DC, Maksimov P, Hotop A, Groß U, Däubener W, Liesenfeld O, Pleyer U, Conraths FJ, Schares G. Genotyping of samples from German patients with ocular, cerebral and systemic toxoplasmosis reveals a predominance of Toxoplasma gondii type II.Int J Med Microbiol. 2014 Oct;304(7):911-6. doi: 10.1016/j.ijmm.2014.06.008.

Meisel R, Heseler K, Nau J, Schmidt SK, Leineweber M, Pudelko S, Wenning J, Zimmermann A, Hengel H, Sinzger C, Degistirici Ö, Sorg RV, Däubener W. Cytomegalovirus infection impairs immunosuppressive and antimicrobial effector functions of human multipotent mesenchymal stromal cells. Mediators Inflamm. 2014;2014:898630. doi: 10.1155/2014/898630

Hotop A, Buschtöns S, Bangoura B, Zöller B, Koethe M, Spekker-Bosker K, Hotop SK, Tenter AM, Däubener W, Straubinger RK, Groß U. Humoral immune responses in chickens and turkeys after infection with Toxoplasma gondii by using recombinant antigens. Parasitol Res. 2014 Apr;113(4):1473-80. doi: 10.1007/s00436-014-3788-x.

Zimmermann A, Hauka S, Maywald M, Le VT, Schmidt SK, Däubener W, Hengel H. Checks and balances between human cytomegalovirus replication and indoleamine-2,3-dioxygenase. J Gen Virol. 2013 Dec 11. doi: 10.1099/vir.0.061994-0.

Spekker K, Leineweber M, Degrandi D, Ince V, Brunder S, Schmidt SK, Stuhlsatz S, Howard JC, Schares G, Degistirici O, Meisel R, Sorg RV, Seissler J, Hemphill A, Pfeffer K, Däubener W. Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs). Med Microbiol Immunol. 2013 Jun;202(3):197-206.

Schmidt SK, Ebel S, Keil E, Woite C, Ernst JF, Benzin AE, Rupp J, Däubener W. Regulation of IDO Activity by Oxygen Supply: Inhibitory Effects on Antimicrobial and Immunoregulatory Functions. PLoS One. 2013 May 13;8(5):e63301.

Heseler K, Schmidt SK, Spekker K, Sinzger C, Sorg RV, Quambusch M, Zimmermann A, Meisel R, Däubener W. Cytomegalovirus impairs the induction of indoleamine 2,3-dioxygenase mediated antimicrobial and immunoregulatory effects in human fibroblasts. PLoS One. 2013 May 15;8(5):e64442.

Schmidt SK, Siepmann S, Kuhlmann K, Meyer HE, Metzger S, Pudelko S, Leineweber M, Däubener W. Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase. PLoS One. 2012;7(9):e44797.

Maksimov P, Zerweck J, Maksimov A, Hotop A, Gross U, Pleyer U, Spekker K, Däubener W, Werdermann S, Niederstrasser O, Petri E, Mertens M, Ulrich RG, Conraths FJ, Schares G. Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans. Clin Vaccine Immunol. 2012 Jun;19(6):865-74.

Maksimov P, Zerweck J, Maksimov A, Hotop A, Gross U, Spekker K, Däubener W, Werdermann S, Niederstrasser O, Petri E, Mertens M, Ulrich RG, Conraths FJ, Schares G. Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarray. PLoS One. 2012;7(3):e34212.

G. Walter-Wenke, C.H. Wirsing von König, W. Däubener, M. Heiden, J. ‚ Hoch, P. Volkers. Monitoring bacterial contamination on blood components in Germany; effect of contamination reduction measures. Vox Sang. 100: 359-366 (2011)

R. Meisel, K. Heseler, H. Bülle, S. Brockers, C. Woite, S. Stuhlsatz, W. Schwippert, R. Henschler, J. Seissler, D. Dilloo and W. Däubener. Human multipotent mesenchymal stromal cells exhibit broad spectrum antimicrobial effector functions mediated by indoleamine 2,3-dioxygenase. Leukemia, 25: 648-654 (2011)

G. Walther-Wenke, W. Däubener, M. Heiden, J. Hoch, B. Hornei, P. Volkers, D.H. Wirsing von König. Effect of safety measures on bacterial contamination rates of blood components in Germany. Transfusions Medicine and Hemotherapy. 38:231-235 (2011)

C. Sattler, M. Steinsdörfer, M. Offers, E. Fischer, R. Schierl, K. Heseler, W. Däubener, J. Seissler. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant. 20:1221-1230 (2011)

A. Roth, P. König, G. van Zandbergen, M. Kling3er, T. Hellwig-Burgel, W. Däubener, M.K. Bohlmann and J. Rupp. Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo. Proc. Nat. Acad. Sci. 107: 19502-19507 (2010)

D. Hinze-Selch, W. Däubener, S. Erdag and S. Wilms. Toxoplasma gondii and the diagnosis of a personality disorder: the host’s response to Toxoplasma gondii  makes a difference. Folia parasitologica 52: 129-135 (2010)

W. Däubener, K.S. Schmidt, K. Heseler and C.R. MacKenzie. Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells. Thrombosis and Haemostasis. 102: 1110-1116 (2009)

S.K. Schmidt, A. Müller, K. Heseler, C. Woite, K. Spekker, C.R. MacKenzie and W. Däubener. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase. Eur. J. Immunology. 29: 275-2764 (2009)

K. Spekker, M. Czesla, V. Ince, K. Heseler, S.K. Schmidt, G. Schares and W. Däubener. Indoleamine 2,3-dioxygenase is involved in the defense against Neospora caninum in human and bovine cells. Infection and Immunity, 77: 4496-4501 (2009)

W. Altiner, S. Wilms, W. Däubener, C. Bormann, M. Pentzek, H.H. Abholz and M. Scherer. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand. J. Prim. Health Care. 27: 70-73 (2009)

A. Müller, K. Heseler, S.K. Schmidt, K. Spekker, C.R. MacKenzie and W. Däubener. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J. Cell. Mol. Med. 13: 1125-1135 (2009)

R. Sorg, X.N. Wang, M. Winter, W. Däubener, M. Rae, A.M. Dickinson, P. Wernet and G. Kögler. Immunomodulatory activity of cord blood derived unrestricted somatic stem cells. J. Cell. Mol. Med. 13: 2465-2475 (2009)

K. Heseler, S. Stuhlsatz, C. Woite, C.R. MacKenzie and W. Däubener. Antimicrobial and immunoregulatory effects mediated by human lung cells. FEMS 52:273-281 (2008)

C.R. MacKenzie, Kathrin Heseler, Anika Müller and W. Däubener. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immunoregulation: tryptophan depletion versus production of toxic kynurenines. Current Drug Metabolism (2007) 8:237-244

D. Hinze-Selch, W. Däubener, L. Eggert, S. Erdag, R. Stoltenberg and S. Wilms. Toxoplasma gondii infection in psychiatric patients: A large scale controlled prospective study in individuals with major depression or schizophrenia. Schizophrenia Bulletin 33:782-788 (2007)

S.D. Brydges, X.W. Zhou, M.H. Huynh, J.M. Harper, J. Mital, K.D.Z. Adjogble, W. Däubener, G.E. Ward and V.B. Carruthers. Targeted deletion of MIC5 enhances trimming proteolysis of Toxoplasma invasion proteins. Eucaryot. Cell 5:2174-2183 (2006)

G. Walther-Wenke, R. Dörner, T. Montag-Lessing, O. Greiss, B. Hornei, R. Knels, J. Strobel, P. Volkers and W. Däubener. Bacterial contamination of  platelet concentrates prepared by different methods: results of standardized sterility testing in Germany. Vox Sang. 90: 177-182 (2006)

R. A. Adam, D. Rüßing, O. Adams, C. Woite, H. Schroten and W. Däubener. Role of human brain microvascular endothelial cells during central nervous system infection. Thrombosis and Haemostasis 94: 341-346 (2005)

C. Mercier, K.Z. Adjogble, W. Däubener, M.F. Cesbron-Delauw. Dense granules: Are they key organelles to help understand the parasitophorous vacuole of all apicomplexa parasites? Int. J. Parasitol. 35:829-849 (2005)

K. Obojes, O. Andres, K. S. Kim, W. Däubener and J. Schneider-Schaulies. Indolamine 2,3-dioxygenase (IDO) mediates cell type specific anti-measles virus activity of interferon-γ. J. Virology 79: 7768-7776 (2005)

J. Türck, C. Oberdörfer, T. Vogel, C.R. MacKenzie and W. Däubener. Enhancement of antimicrobial effects by glucocorticoids. Med. Microb. Immunol 194: 47-53 (2005)

K.D.Z. Adjogble, C. Mercier, J.F. Dubremetz, C. Hucke, C.R. MacKenzie, M.F. Cesbron-Delauw and W. Däubener. GRA9, a new Toxoplasma dense granule protein associated with the intravacuolar network of tubular membranes. Int. J. Parasitol. 34:1255-1264 (2004)

A. Giese, W. Däubener and C.R. MacKenzie. Inhibition of the growth of Toxoplasma gondii in immature human dendritic cells is dependent on the expression of TNF-α receptor2. J. Immunology 173: 3366-3374 (2004)

O. Adams, K. Besken, C. Oberdörfer, C.R. MacKenzie, D. Rüßing and W. Däubener. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indolamine 2,3-dioxygenase. Microbes and Infection 6: 806-812 (2004)

R.A. Adam, T. Tenenbaum, P. Valentin-Weigand, M. Laryea, B. Schwahn, S. Angelow, H.J. Galla, W. Däubener and H. Schroten. Porcine choroids plexus epithelial cells induce streptococcus suis bacteriostasis in vitro. Infect. Immun. 72:3084-3087 (2004)

C. Hucke, C.R. MacKenzie, K.D.Z. Adjogble, O. Takikawa and W. Däubener. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: Inhibiition and degradation of human indolamine 2,3-dioxygenase. Infection and Immunity 72: 2723-2730 (2004)

O. Adams, K. Besken, C. Oberdörfer, C.R. MacKenzie, O. Takikawa and W. Däubener. Role of indolamine 2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virology 78:2632-2636    (2004)

R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Däubener and D. Dilloo. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indolamine 2,3-dioxygenase mediated tryptophan degradation. Blood 103: 4619-4621 (2004)

M. Cohnen, R. Luthen, W. Däubener, A. Saleh, J. Bode, D. Häussinger and U. Mödder. Predictive parameters of infectiologic complications in patients after TIPPS. Radiologe 43:155-160 (2003)

M. Cohnen, R. Luthen, W. Däubener and U. Mödder. Lack of portosystemic bacterial translocation in patients with liver cirrhosis after placement of transjugular shunt. Eur. J. Clin. Microbiol. Infect Dis. 22:310-312 (2003)

C. Bormann, W. Däubener, H.H. Abholz and A. Altiner. Bakterielle Erreger und Resistenzen bei 232 Patienten mit akutem produktivem Husten. Z. Allg. Med. 79: 193-199 (2003)

C. Oberdörfer. O. Adams, C.R. MacKenzie, C.J.A. de Groot and W. Däubener. Role of IDO activation in anti-microbial defence in human native astrocytes. Advances Exp. Med. Biol. 527: 15-26 (2003)

C.R. MacKenzie, D Worku and W. Däubener. Regulation of IDO-mediated bacteriostasis in macrophages: Role of antibiotics and anti-inflammatory agents. Advances Exp. Med. Biol. 527:67-76 (2003)

T. Montag Lessing, W. Däubener, R. Dörner, O. Greis, B. Hornei, J. Strobel and G. Walther-Wenke. Einführung des „Predonation Sampling“. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 45: 756  2002

H. Spelsberg, T. Reinhard, U. Sengler, W. Däubener and R. Sundmacher. Organ-cultured corneal grafts from septic donors: a retrospective study. Eye 16:622-627 (2002)

W. Däubener und Colin R. MacKenzie. (2001) Regulation der lokalen Tryptophankonzentration: Ein anti-mikrobieller und immunregulatorischer Effektormechanismus? Hygiene und Mikrobiologie 5:177-182

W. Däubener, B. Spors, C. Hucke, P. Gudowius, M. Stins, K.S. Kim and H. Schroten. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infection and Immunity 69:6527-6531 (2001)

H. Schroten, B. Spors, C. Hucke, M. Stins, K.S. Kim and W. Däubener. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess - inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. J. Neuropediatrics 32:206-210 (2001)

S.D. Brydges, G.D. Sherman, S. Nockemann, A. Loyens, W. Däubener, J.F. Dubremetz and V.B. Carruthers. Identification of novel micronemal proteins in Toxoplasma gondii and molecular characterization of TgMIC5. Mol. Biochem. Parasitol. 111: 51-66 (2000)

C.R. MacKenzie, R. Langen, O. Takikawa and W. Däubener. Inhibition of indolamine 2,3-dioxygenase in human macrophages inhibits interferon-? induced bacteriostasis but does not abrogate toxoplasmastasis. Eur. J. Immunol. 29:3254-3261 (1999)

T. Montag-Lessing, B. Baumann, W. Däubener, R. Dörner, M. Exner, L. Kriszck, H. Lange, H. Trobisch, G. Walther-Wenke, E. Werner and J. Hoch. Herstellung kontaminationssicherer Schlauchverbindungen bei Blutbeuteln – Stellungnahme des Arbeitskreises Blut des Bundesgesministeriums für Gesundheit. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 43: 366  1999

W. Däubener, C. Hucke, K. Seidel, U. Hadding and C.R. Mackenzie. IL-1 inhibits IFN-γ induced bacteriostasis in human uroepithelial cells. Infection and Immunity, 67:5615-5620 (1999)

C.R. MacKenzie, D. Müller, C. Hucke, K. Seidel and W. Däubener. IFN-y activated uroepithelial cells inhibits the growth of multiresistent enterococci. J. Med. Microb. 48:935-941 (1999)

W. Däubener and C.R. Mackenzie. IFN-y activated indolamine 2,3-dioxygenase activity in human cells is an anti-parasitic and an anti-bacterial effector mechanism. Advances in Exp. Med. Biol.467:517-524 (1999)

W. Däubener, C.R. Mackenzie, V. Posdziech and U. Hadding. Inducible anti-parasitic effector mechanisms in human uroepitehlial cells: tryptophan degradation vs. NO production. Medical Microbiology and Immunology, 187: 143-147 (1999)

S. Nockemann, H. Dlugonska, B. Henrich, A. Kitzerow and W. Däubener. Expression, characterization and serological reactivity of a 41 kDa excreted-secreted antigen from Toxoplasma gondii. Mol. Biochem. Parasitiology 97: 109-121 (1998)

C. R. Mackenzie and W. Däubener. Inhibition of group B streptococcal growth by IFN-γ activated human glioblastoma cells. J. Neuroimmunol. 89: 191-197 (1998)

C.R. Mackenzie, U. Hadding and W. Däubener. Interferon gamma induced activation of indolamine 2,3-dioxygenase in cord blood monocyte-derived-macrophages inhibits the growth of group B streptococci. J. Infect. Dis. 178: 875-878 (1998)

E. Nettelbreker, H. Zeidler, H. Bartels, U. Dreses-Werringloer, W. Däubener, H. Holtmann and L. Köhler. Persistant infection of Chlamydia trachomatis in TPA-differentiated U937 cells is not modulated by IFN-γ. J. Med. Microbiol. 47: 141-149 (1998)

W. Däubener and U. Hadding. Cellular immunereactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Medical Microbiology and Immunology 185:195-206 (1997)

G. Kögler, J. Callejas, P. Hakenberg, J. Enczmann, O. Adams, W. Däubener, C. Krempe, U. Göbel, T. Somville and P. Wernet. Hematopoietic tansplant potential of unrelated cord blood: critical issues. Hematotherapy 5:105-116 (1996)

W. Däubener, M. Gutsche, C. MacKenzie, S. Seghrouchni and U. Hadding. Protamine enhances the activity of human recombinant Interferon gamma. J. Interferon and Cytokine Res. 16:533-538 (1996)

W. Däubener, C. Remscheid, S. Nockemann, K. Pilz and U. Hadding. Anti-parasitic effector-mechanisms in human brain cells: Role of interferon gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 26:487-492 (1996)

Th. Somville, G. Kögler, O. Adams, C. Krempe, W. Däubener, U. Göbel, H. G. Bender and P. Wernet. Plazentares Restblut als Stammzelltransplantat. Perinatalmedizin 8: 93-99 (1996)

W. Däubener, C. MacKenzie and U. Hadding. Establishment of TH1- and TH2-like human toxoplasma-antigen specific T-cell clones. Immunology 86: 79-84 (1995)

W. Däubener, S. Nockemann and U. Hadding. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant Interferon gamma. Eur. J. Immunol. 25:688-692 (1995)

H. Köller, W. Däubener, K. Pilz and M. Siebler. Lipopolysaccharides and leukotriene B4 induce independently regulated electrophysiological and immunological responses in cultured astrocytes. J. Neuroimmunology 55:179-185 (1994)

W. Däubener, N. Wanagat, K. Pilz, S. Seghrouchni, H. G. Fischer and U. Hadding. A new and simple bioassay for human IFN-y. J. Immunol. Meth. 168: 39-47 (1994)

M. Lahn, G. Tyler, W. Däubener and U. Hadding. Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-Page. Eur. J. Epidem. 9: 327-334 (1993)

H. G. Fischer, A. K. Bielinsky, B. Nitzgen, W. Däubener and U. Hadding. Functional dichotomy of mouse microglia developed in vitro: Differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity. J. Neuroimmunol. 45: 193-202 (1993)

W. Däubener, K. Pilz, S. Seghrouchni Zennati, T. Bilzer, H. G. Fischer and U. Hadding. Induction of toxoplasmostasis in a human glioblastoma by interferon-y. J. Neuroimmunol. 43: 31-38 (1993)

H.G. Fischer, B. Nitzgen, T. Germann, K. Degitz, W. Däubener and U. Hadding. Differentiation driven by granulocyte-macrophage colony stimulating factor endows microglia with Interferon-y-independent antigen presenting function. J. Neuroimmunol. 42: 87-96 (1993)

W. Däubener, S. Seghrouchni Zennati, P. Wernet, T. Bilzer, H. G. Fischer and U. Hadding. Human glioblastoma cell line 86HG39 activates T cells in an antigen specific major histocompatibility complex class II-dependent manner. J. Neuroimmunol. 41: 21-28 (1992)

W.A. Flegel, F. Müller, W. Däubener, H. G. Fischer, U. Hadding and H. Northoff. Cytokine response by human monocytes to Clostridium difficile Toxin A and Toxin B. Infect. Immun. 59: 3659-3666 (1991)

K. Schmitt, W. Däubener, D. Bitter-Suermann and U. Hadding. A safe and efficient method for elimination of cell culture mykoplasmas using ciprofloxacin. J. Immunol. Meth. 109: 17-25 (1988)

W. Däubener, E. Leiser, C. von Eichel-Streiber and U. Hadding. Clostridium difficile Toxins A and B inhibit human immune response in vitro. Infect. Immun. 56: 1107-1112 (1988)

W. Däubener, B. Faßbender, S. Meuer, D. Bitter-Suermann and U. Hadding. Suppressive effects of C3b on monocyte-dependent T cell proliferation. Eur. J. Immunol. 17: 1775-1779 (1987)

W. Däubener, D. von Steldern, B. Maxeiner, P. Scheurich and K. Pfizenmaier. Postnatal development of functional T cell subsets in the mouse: a frequency analysis of mitogen reactive precursors of proliferating, of cytotoxic and of Il-2 producing T cells. Immunobiology 169: 472-485 (1985)

K. Pfizenmaier, P. Scheurich, W. Däubener, M. Krönke, M. Röllinghoff and H. Wagner. Quantitative representation of all T cells committed to develop into cytotoxic cells and/or interleukin 2 activity-producing helper cells within murine T lymphocyte subsets. Eur. J. Immunol. 14: 33-39 (1984)

MediathekInformation und Wissen
LageplanSo finden Sie uns